Brief: BVF Inc Reports 9.6% Passive Stake In Protagonist Therapeutics Inc Common Stock As Of March 10 - SEC Filing
March 20 (Reuters) - Protagonist Therapeutics Inc
PTGX.O :
* BVF INC REPORTS 9.6% PASSIVE STAKE IN PROTAGONIST
THERAPEUTICS
INC COMMON STOCK AS OF MARCH 10 - SEC FILING
Further company coverage: PTGX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagonist Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary